Back to the main directory
Press Release
- Worksport Secures ISO 9001 Certification at U.S. Factory, Unlocking Revenue & OEM Growth Pathways by GlobeNewsWire
- Oragenics, Inc. Announces One-for-Thirty Reverse Stock Split by GlobeNewsWire
- Kraig Biocraft Laboratories Announces New Spider Silk Parental Strain for Expanded Commercial Production by GlobeNewsWire
- PyroGenesis Confirms Receiving Accelerated Customer Request for Fumed Silica Samples by GlobeNewsWire
- Brixton Metals Commences Drilling at its Thorn Copper-Gold Project by GlobeNewsWire
- MediPharm Labs Board Issues Letter to Shareholders in Response to Inadequate Dissident Plan by GlobeNewsWire
- All resolutions approved at the 2025 STMicroelectronics' Annual General Meeting of Shareholders by GlobeNewsWire
- Indberetningspligtiges transaktioner med Djurslands Bank A/S by GlobeNewsWire
- Alpha Modus Holdings Inc. (NASDAQ: AMOD) to Allocate 25% of Forward Revenue into Crypto Assets, Citing MicroStrategy Model and Leveraging CashX™ Infrastructure by GlobeNewsWire
- NV5 Awarded $10 Million Location and Surveys Contract by North Carolina Department of Transportation by GlobeNewsWire
- Vera Bradley, Inc. Announces Reporting Date for First Quarter Fiscal Year 2026 Results by GlobeNewsWire
- Rackspace Technology Recognized by Dell Technologies with Two Regional Global Alliances Partner of the Year Awards for 2025 by GlobeNewsWire
- 4DMT to Participate in Upcoming Investor Conferences by GlobeNewsWire
- Element Demonstrates Progress on Climate Strategy and Enhanced Transparency in Latest Sustainability Report by GlobeNewsWire
- Mesa Labs Announces Fourth Quarter and Full Fiscal Year 2025 Results by GlobeNewsWire
- Axogen, Inc to Participate at Goldman Sachs Global Healthcare Conference by GlobeNewsWire
- Solid Biosciences to Participate at the Jefferies Global Healthcare Conference by GlobeNewsWire
- Milestone Pharmaceuticals to Present at the Jefferies Global Healthcare Conference by GlobeNewsWire
- Rezolute Announces Completion of Enrollment in the Phase 3 sunRIZE Study of Ersodetug in Patients with Congenital Hyperinsulinism by GlobeNewsWire
- Halberd, Athena GTX, Inc. & Athena Telemedicine Partnership, LLC Clinical Study Updates by GlobeNewsWire
- Cocrystal Pharma to Participate in Noble Capital Markets’ 2025 Emerging Growth Virtual Equity Conference by GlobeNewsWire
- Hudbay Receives TSX Approval for Normal Course Issuer Bid by GlobeNewsWire
- Vaxart Answers Additional Frequently Asked Questions from Retail Investors by GlobeNewsWire
- Roadzen to Participate in Fireside Chat at the Maxim Group’s “2025 Virtual Tech Conference: Discover the Innovations Reshaping Tomorrow” on Tuesday, June 3, 2025 by GlobeNewsWire
- Wave Life Sciences Announces Appointment of Dr. Christopher Wright as Chief Medical Officer by GlobeNewsWire